VoSpire® ER Tablets 8 mg

DRUG2 trials

Sponsors

Mylan Pharmaceuticals Inc

Conditions

Healthy

Phase 1

Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg

CompletedNCT00649987

Mylan Pharmaceuticals IncHealthy

Start: 2005-09-30End: 2005-10-31Updated: 2024-04-24

Fasting Bioequivalence Study of Nisoldipine Extended-Release Tablets 40 mg

CompletedNCT00730197

Mylan Pharmaceuticals IncHealthy

Start: 2007-02-28End: 2007-03-31Updated: 2008-08-08